Estrogen receptor alpha and beta (ERα and ERβ)

Estrogen receptors alpha and beta are intracellular, ligand-activated transcription factors belonging to the nuclear receptor superfamily, specifically the steroid hormone receptor group. They are encoded by distinct genes (ESR1 for ERα on chromosome 6, ESR2 for ERβ on chromosome 14) and exhibit homology in DNA-binding and ligand-binding domains but differ in tissue distribution, functional roles, and pharmacological properties. Upon binding estrogen or pharmacological modulators, these receptors undergo conformational change, dimerize (as homodimers or heterodimers), and regulate gene expression via binding estrogen response elements in DNA. ERα and ERβ have overlapping but distinct roles in development, reproduction, metabolism, cardiovascular homeostasis, and disease pathology. Both are major targets for drugs in cancer and endocrine disorders, though the combined name "Estrogen Receptor α/β" is not the proper canonical designation for structured purposes.

Other names

ERαER betaNR3A1 (ERα)NR3A2 (ERβ)ESR1 (gene for ERα)ESR2 (gene for ERβ)Estrogen nuclear receptor alpha/beta

Agonists trigger conformational changes leading to DNA binding and gene transcription; Antagonists block ligand binding, preventing receptor activation and encouraging receptor degradation or altered gene regulation; Selective estrogen receptor modulators (SERMs) exert tissue-specific agonist or antagonist effects